title: Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study.
abstract: OBJECTIVE
  Hypertension is common among patients with dyslipidemia but is often poorly treated. The objective of this analysis was to evaluate how a decision aid, used by primary care physicians to improve lipid therapy, impacted on the treatment of hypertension.
  
  
  METHODS
  Data were analyzed from patients enrolled in a randomized trial focusing primarily on the treatment of dyslipidemia. Patients received usual care or a coronary risk profile every three months to monitor the risk reduction following lifestyle changes and/or pharmacotherapy to treat dyslipidemia. Hypertension management was assessed based on a post hoc analysis of individuals whose blood pressure exceeded current national hypertension guidelines.
  
  
  RESULTS
  There were 2,631 subjects who completed the study. Among 1,352 patients without diagnosed hypertension, 30% were above target on at least three consecutive visits. Among 1,279 individuals with known hypertension, 69% were above target on at least two consecutive visits. Overall, patients receiving risk profiles were more likely to receive appropriate antihypertensive therapy (OR = 1.40, 95% CI 1.11-1.78) compared to those receiving usual care. After adjustment for inter-physician variability and potential confounders, the use of the risk profile was associated with an increased likelihood of starting therapy (OR = 1.78, 95% CI 1.06-3.00) or modifying therapy (OR = 1.40, 95% CI 1.03-1.91).
  
  
  CONCLUSIONS
  In this clinical trial of dyslipidemia management, inadequately controlled hypertension was common, occurring in nearly 50% of individuals. Ongoing coronary risk assessment was associated with more appropriate blood pressure management. Cardiovascular risk assessment decision aids should be further evaluated in a randomized trial of hypertension therapy.
authors.affiliation: McGill Cardiovascular Health Improvement Program, The McGill University Health Centre, Montreal, Canada. steven.grover@mcgill.ca
authors.forename: Steven A
authors.initials: SA
authors.lastname: Grover
authors.forename: Ilka
authors.initials: I
authors.lastname: Lowensteyn
authors.forename: Lawrence
authors.initials: L
authors.lastname: Joseph
authors.forename: Mohammed
authors.initials: M
authors.lastname: Kaouache
authors.forename: Sylvie
authors.initials: S
authors.lastname: Marchand
authors.forename: Louis
authors.initials: L
authors.lastname: Coupal
authors.forename: Ghislain
authors.initials: G
authors.lastname: Boudreau
mesh_terms: D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000517:prevention & control / Q000523:psychology / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000517:prevention & control / Q000523:psychology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000523:psychology; D010353:Patient Education as Topic / Q000379:methods*; D010817:Physician-Patient Relations; D012307:Risk Factors; D016896:Treatment Outcome